Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 19.85
+0.05 (0.25%)
Jan 22, 2026, 10:24 AM CST
Adimmune Revenue
Adimmune had revenue of 475.32M TWD in the quarter ending September 30, 2025, a decrease of -46.49%. This brings the company's revenue in the last twelve months to 1.20B, down -23.56% year-over-year. In the year 2024, Adimmune had annual revenue of 1.56B, down -12.78%.
Revenue (ttm)
1.20B
Revenue Growth
-23.56%
P/S Ratio
6.95
Revenue / Employee
2.13M
Employees
503
Market Cap
8.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.56B | -228.11M | -12.78% |
| Dec 31, 2023 | 1.79B | -466.53M | -20.72% |
| Dec 31, 2022 | 2.25B | 457.85M | 25.52% |
| Dec 31, 2021 | 1.79B | -75.37M | -4.03% |
| Dec 31, 2020 | 1.87B | 569.46M | 43.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEngine | 2.51B |
| Savior Lifetec | 1.16B |
| TCM Biotech International | 682.40M |
| Mycenax Biotech | 649.64M |
| Pharmosa Biopharm | 136.72M |
| OBI Pharma | 49.29M |
| TaiGen Biopharmaceuticals Holdings | 38.75M |
| Gongwin Biopharm Holdings | 37.46M |